Chen W, McRoberts J A, Marvizón J C G
Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, United States; Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA 90095, United States.
Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, United States; Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA 90095, United States.
Neuroscience. 2014 May 16;267:67-82. doi: 10.1016/j.neuroscience.2014.02.023. Epub 2014 Feb 26.
Opiate analgesia in the spinal cord is impaired during neuropathic pain. We hypothesized that this is caused by a decrease in μ-opioid receptor inhibition of neurotransmitter release from primary afferents. To investigate this possibility, we measured substance P release in the spinal dorsal horn as neurokinin 1 receptor (NK1R) internalization in rats with chronic constriction injury (CCI) of the sciatic nerve. Noxious stimulation of the paw with CCI produced inconsistent NK1R internalization, suggesting that transmission of nociceptive signals by the injured nerve was variably impaired after CCI. This idea was supported by the fact that CCI produced only small changes in the ability of exogenous substance P to induce NK1R internalization or in the release of substance P evoked centrally from site of nerve injury. In subsequent experiments, NK1R internalization was induced in spinal cord slices by stimulating the dorsal root ipsilateral to CCI. We observed a complete loss of the inhibition of substance P release by the μ-opioid receptor agonist [D-Ala(2), NMe-Phe(4), Gly-ol(5)]-enkephalin (DAMGO) in CCI rats but not in sham-operated rats. In contrast, DAMGO still inhibited substance P release after inflammation of the hind paw with complete Freund's adjuvant and in naïve rats. This loss of inhibition was not due to μ-opioid receptor downregulation in primary afferents, because their colocalization with substance P was unchanged, both in dorsal root ganglion neurons and primary afferent fibers in the dorsal horn. In conclusion, nerve injury eliminates the inhibition of substance P release by μ-opioid receptors, probably by hindering their signaling mechanisms.
在神经性疼痛期间,脊髓中的阿片类镇痛作用受损。我们推测这是由于μ-阿片受体对初级传入神经递质释放的抑制作用减弱所致。为了研究这种可能性,我们测量了坐骨神经慢性压迫损伤(CCI)大鼠脊髓背角中P物质的释放,作为神经激肽1受体(NK1R)的内化情况。用CCI对爪子进行伤害性刺激产生了不一致的NK1R内化,这表明CCI后受损神经对伤害性信号的传递受到了不同程度的损害。这一观点得到了以下事实的支持:CCI对外源性P物质诱导NK1R内化的能力或从神经损伤部位中枢诱发的P物质释放仅产生了微小变化。在随后的实验中,通过刺激CCI同侧的背根在脊髓切片中诱导NK1R内化。我们观察到,μ-阿片受体激动剂[D-丙氨酸(2),N-甲基苯丙氨酸(4),甘氨醇(5)]-脑啡肽(DAMGO)对CCI大鼠中P物质释放的抑制作用完全丧失,但在假手术大鼠中未丧失。相比之下,在后爪用完全弗氏佐剂炎症后以及在未处理的大鼠中,DAMGO仍然抑制P物质的释放。这种抑制作用的丧失并非由于初级传入神经中μ-阿片受体的下调,因为在背根神经节神经元和背角中的初级传入纤维中,它们与P物质的共定位没有改变。总之,神经损伤消除了μ-阿片受体对P物质释放的抑制作用,可能是通过阻碍其信号传导机制实现的。